---
format: "aidr-story-markdown/v1"
id: "cc9619ebb68e17436968b64a89ada58659cfe51f0f537bd1b05cf10a1c201428"
canonical_url: "https://aidr.today/cc9619eb?lang=en"
title: "Isomorphic Labs and Merck Partner to Design AI Cancer Drug"
lang: "en"
requested_lang: "en"
available_langs: ["en","vi"]
translation_fallback: null
fallback_fields: []
published_at: "2026-11-20T20:21:29.000Z"
category: "Industry"
topics: ["google"]
source_urls: ["https://marketbrief.now/ai/isomorphic-labs-and-merck-partner-to-design-ai-cancer-drug-8266abe9","https://huggingnews.com/ai/isomorphic-labs-and-merck-partner-to-design-ai-cancer-drug-8266abe9"]
summary: "Isomorphic Labs and Merck have entered a strategic research collaboration to design a new cancer drug."
---

# Isomorphic Labs and Merck Partner to Design AI Cancer Drug

> [Open the canonical story](<https://aidr.today/cc9619eb?lang=en>)

**Published:** 2026-11-20T20:21:29.000Z
**Category:** Industry
**Topics:** google

## Summary

Isomorphic Labs and Merck have entered a strategic research collaboration to design a new cancer drug\.

## Sources

- [Story source](<https://marketbrief.now/ai/isomorphic-labs-and-merck-partner-to-design-ai-cancer-drug-8266abe9>)
- [Story source](<https://huggingnews.com/ai/isomorphic-labs-and-merck-partner-to-design-ai-cancer-drug-8266abe9>)

